CVEvulnerability
CVE-2016-8358
8.5 HIGH
Official page ↗
- Status
- Modified
- Published
- 2017-02-13
- Last modified
- 2026-06-17
- Assigner
- [email protected]
- CVSS 3.0 ([email protected])
- 8.5 HIGH — CVSS:3.0/AV:N/AC:H/PR:L/UI:N/S:C/C:H/I:H/A:H
- CVSS 2.0 ([email protected])
- 6.0 MEDIUM — AV:N/AC:M/Au:S/C:P/I:P/A:P
- Weaknesses
- CWE-346
Description
An issue was discovered in Smiths-Medical CADD-Solis Medication Safety Software, Version 1.0; 2.0; 3.0; and 3.1. The affected software does not verify the identities at communication endpoints, which may allow a man-in-the-middle attacker to gain access to the communication channel between endpoints.
Affected configurations
• smiths-medical cadd-solis medication safety software 1.0
• smiths-medical cadd-solis medication safety software 2.0
• smiths-medical cadd-solis medication safety software 3.0
• smiths-medical cadd-solis medication safety software 3.1
Related
Weakness · CWE (1)
- CWE-346 Origin Validation Error weakness
References
- http://www.securityfocus.com/bid/94630 Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01 Third Party Advisory, US Government Resource
- http://www.securityfocus.com/bid/94630 Third Party Advisory, VDB Entry
- https://ics-cert.us-cert.gov/advisories/ICSMA-16-306-01 Third Party Advisory, US Government Resource